Patienter i grupperne med aktiv behandling fortsatte til uge 24 på den dosis, de oprindeligt blev randomiseret til.
After 12 weeks of treatment, patients in the placebo group began treatment with blinded Enbrel (25 mg twice a week); patients in the active treatment groups continued to week 24 on the dose to which they were originally randomised.